TrianglePUBLICATIONS · 23775972
Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2013 Jul 20
- First author
- Eckert C
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Eckert C
- type
- Author
- name
- Henze G
- type
- Author
- name
- Seeger K
- type
- Author
- name
- Hagedorn N
- type
- Author
- name
- Mann G
- type
- Author
- name
- Panzer-Grümayer R
- type
- Author
- name
- Peters C
- type
- Author
- name
- Klingebiel T
- type
- Author
- name
- Borkhardt A
- type
- Author
- name
- Schrappe M
- type
- Author
- name
- Schrauder A
- type
- Author
- name
- Escherich G
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Eckert C
- type
- Author
- name
- Henze G
- type
- Author
- name
- Seeger K
- type
- Author
- name
- Hagedorn N
- type
- Author
- name
- Mann G
- type
- Author
- name
- Panzer-Grümayer R
- type
- Author
- name
- Peters C
- type
- Author
- name
- Klingebiel T
- type
- Author
- name
- Borkhardt A
- type
- Author
- name
- Schrappe M
- type
- Author
- name
- Schrauder A
- type
- Author
- name
- Escherich G
- type
- Author
- bibliography ids
- nci-bib-af6516c1c174269e0d712f2b
- book metadata
- content sha256
- 864f26240662957b3463f483a9977d529ba8b9e8b5d0a0a75eca2fec75ce63f2
- document type
- citation
- dois
- 10.1200/JCO.2012.48.5680
- electronic publication date
- display
- 2013 Jun 17
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23775972
- immutable id
- pubmed:23775972@864f26240662957b3463f483a9977d529ba8b9e8b5d0a0a75eca2fec75ce63f2
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 21
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2736-42
- volume
- 31
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23775972
- provenance
- batch id
- 0a08f044391426feb8ef
- provider
- NCBI PubMed ESummary
- record sha256
- 1873014c9f785ad9a60ec154c874c645dd93b1fff9ab2dbc047c1c89d8340b27
- response sha256
- d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
- retrieved at
- 2026-09-09T23:46:57.614689+00:00
- publication date
- display
- 2013 Jul 20
- precision
- day
- year
- 2013
- publication types
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.
Preserved source evidence · Not medical advice